A BRIGHT SOLUTION FOR DRY EYES

DRY EYE MEDICAL DEVICE

Lumenis, the inventor of IPL, presents the first and only IPL FDA-approved for the management of dry eye disease due to MGD.

Introducing OptiLIGHT – a bright solution for dry eyes. OptiLIGHT elevates dry eye management with Lumenis’ patented Optimal Pulse Technology (OPT™) and user-centered design. Get the safe, precise, elegant procedure you want and the comfortable, effective therapy your patients need to manage dry eye disease with OptiLIGHT, a dry eye medical device.

DRY EYE MEDICAL DEVICE

Every element designed to provide a precise and comfortable Dry Eye procedure

Patented OPT™ Handpiece

Patented OPT™ Handpiece

Each of your patients has individual, delicate facial contours. With the patented OPT™ handpiece, the treatment is easily customized to fit every curve and outline.

Ergonomic IPL Handpiece

Ergonomic IPL Handpiece

Treat wider areas safely and comfortably using the IPL handpiece with patented SapphireCool™ technology to effectively break dry eye vicious cycle of inflammation.

Proven Settings And Protocols

Proven Settings And Protocols

Utilize embedded settings based on Lumenis’ clinically validated treatment protocols for safe and effective dry eye treatment.

Tailored Experience For Maximum Safety And Comfort

Tailored Experience For Maximum Safety And Comfort

Experience optimal energy control with the Opti -Tip, which optimizes light energy for delicate areas, ensuring a safe, hygienic and effective treatment.

Optimal Pulse Technology (OPT™) That Transforms Light-Based Therapy

Optimal Pulse Technology (OPT™) That Transforms Light-Based Therapy

Get targeted, precise and controlled treatment with OptiLIGHT’s patented OPT™ technology – optimal energy with no-spike consistency.

DRY EYE MEDICAL DEVICE

Every element designed to provide a precise and comfortable Dry Eye procedure

Reduce Inflammatory Mediators

Decrease the level of pro-inflammatory mediators to inhibit inflammation.1,2

Improve Tear Breakup Time

Significantly boost tear break up time and decrease osmolarity.6,7

Alleviate Abnormal Blood Vessels

Destroy the abnormal blood vessels that perpetuate inflammation.3,4

Restore Meibomian Glands

Improve meibomian gland morphology and functionality.2

Decrease Demodex

Decrease the population of Demodex mites, which stimulate infection and boost the bacterial load on eyelids.5

Frequently Asked Questions

What is OptiLIGHT?

OptiLIGHT is a light-based treatment that uses precise, intense broad spectrum light to address signs of dry eye disease due to meibomian gland dysfunction (MGD). MGD is the most common cause of dry eye disease, accounting for about 86% of cases8. The treatment addresses inflammation, which is one of the key underlying factors in MGD. OptiLIGHT was specifically developed to reach the delicate contours of the treated area safely, effectively, and gently using the OPT™ technology. It is intended for use in patients who are at least 22 years old, together with other available treatments, such as Meibomian gland expression, artificial tear lubricants, and warm compresses.

Is Lumenis light therapy FDA approved?

Lumenis light therapy is the first and only IPL FDA approved for Dry Eye management due to Meibomian Glands Dysfunction (MGD).

What are the key features of OptiLIGHT?
  • Patented OPTTM handpiece
  • Ergonomic IPL handpiece
  • Personalized experience for safety and comfort
  • Proven setting and protocols
  • Transforming the use of light with OPTTM technology
How long does it take to perform a procedure with OptiLIGHT?

Each treatment takes about 15 minutes, so you can easily integrate OptiLIGHT into the workflow. Patients achieve results in just 4 comfortable OptiLIGHT treatments.

Is there any downtime after a procedure with OptiLIGHT?

Immediately following treatment, patients may experience some redness. This will usually disappear within a few hours.
Patients can resume their daily activities according to their doctor’s recommendation.

What is OPT™ technology?

Lumenis’ patented technology OPT™ (Optimal Pulse Technology) transforms the use of light and allows targeted, uniform, precise, and controlled treatment. Specifically designed for the delicate area below the eye, OPT™ safely and effectively breaks the vicious cycle of inflammation associated with dry eye.

What is the wavelength of the OptiLIGHT system?

The wavelength range of IPL is between 400 and 1200 nm. The OptiLIGHT system limited the wavelength range to of 590-1200 nm obtained with the use of a cut-off filter of 590 nm.

Elevating Your Dry Eye Practice

Light-based, quick, 15-Minute Procedure

Each OptiLIGHT session takes about 15 minutes, so you can easily integrate OptiLIGHT into your practice. With a seamless workflow and just 4 easy-to-perform sessions, OptiLIGHT is an essential tool in your dry eye toolkit. Elevate clinical effectiveness, practice efficiency and business growth with OptiLIGHT, dry eye medical device.